Ellis Bio, a developer of next-generation epigenomics technologies, today announced the official commercial launch of its SuperMethyltm Max Bisulfite Conversion Kit, a new and gentle methyl conversion ...
Morning Overview on MSN
Scientists uncover genetic switch that makes pancreatic cancer chemo-proof
Researchers at Duke-NUS Medical School have identified a molecular switch controlled by the protein GATA6 that determines whether pancreatic cancer cells respond to chemotherapy or become resistant.
In RNA-seq library preparation, selecting the appropriate number of PCR cycles is a critical balancing act to avoid overcycling.
Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.
Interesting Engineering on MSN
US scientists build first rewritable DNA hard drive for molecular data storage
DNA data storage has recently entered a new phase of development, as scientists in ...
Tina de los Reyes is the strategic biopharma development specialist for the Western US. With over 10 years of commercial experience in NGS and a Masters in Biomedical diagnostics, she specializes in ...
Haoyu Cheng, Ph.D., assistant professor of biomedical informatics and data science at Yale School of Medicine, has developed a new algorithm capable of building complete human genomes using standard ...
Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.
Current clinical challenges in Hodgkin lymphoma (HL) include difficult-to-treat relapsed/refractory disease and considerable long-term toxicities of treatment. Since clinical risk factors lack ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results